These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 13446379)

  • 1. The action of ergotamine on the intracranial venous pressure and on the cerebral venous outflow of the dog.
    CARPI A; VIRNO M
    Br J Pharmacol Chemother; 1957 Jun; 12(2):232-9. PubMed ID: 13446379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary observations on the influence of ergotamine and dihydroergotamine on cerebral blood flow in the dog.
    ABREU BE; LIDDLE GW
    Fed Proc; 1947; 6(1):304. PubMed ID: 20343633
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed.
    Aellig WH; Berde B
    Br J Pharmacol; 1969 Jul; 36(3):561-70. PubMed ID: 5789809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of ergotamine and dihydroergotamine on cerebral blood flow in man.
    Andersen AR; Tfelt-Hansen P; Lassen NA
    Stroke; 1987; 18(1):120-3. PubMed ID: 3810743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ].
    Aellig WH
    Cardiology; 1976; 61 suppl 1():302-8. PubMed ID: 975144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy.
    Silberstein SD; McCrory DC
    Headache; 2003 Feb; 43(2):144-66. PubMed ID: 12558771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
    Tfelt-Hansen PC; Koehler PJ
    Cephalalgia; 2008 Aug; 28(8):877-86. PubMed ID: 18460007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of ergotamine, dihydroergotamine and hydergine in the reserpine-treated rabbit].
    SCHMITT H
    C R Seances Soc Biol Fil; 1959; 153():748-9. PubMed ID: 14443140
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of dihydroergotamine on cerebral circulation during experimental intracranial hypertension.
    Nilsson F; Messeter K; Grände PO; Rosén I; Ryding E; Nordström CH
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):916-21. PubMed ID: 8848892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carotid vascular effects of ergotamine and dihydroergotamine in the pig: no exclusive mediation via 5-HT1-like receptors.
    den Boer MO; Heiligers JP; Saxena PR
    Br J Pharmacol; 1991 Sep; 104(1):183-9. PubMed ID: 1664762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of drugs on the cerebral circulation of the dog in relation to the cerebral oxygen consumption.
    Chin WP; Imai S; Nakano U; Takeda K; Tamatsu H; Ushijima T
    Br J Pharmacol; 1983 Aug; 79(4):897-906. PubMed ID: 6418251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine external carotid vasoconstriction to methysergide, ergotamine and dihydroergotamine: role of 5-HT1B/1D receptors and alpha2-adrenoceptors.
    Villalón CM; De Vries P; Rabelo G; Centurión D; Sánchez-López A; Saxena P
    Br J Pharmacol; 1999 Feb; 126(3):585-94. PubMed ID: 10188968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral vasoconstriction by indomethacin in intracranial hypertension. An experimental investigation in pigs.
    Nilsson F; Björkman S; Rosén I; Messeter K; Nordström CH
    Anesthesiology; 1995 Dec; 83(6):1283-92. PubMed ID: 8533921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of ergotamine and dihydroergotamine.
    Silberstein SD
    Headache; 1997; 37 Suppl 1():S15-25. PubMed ID: 9009470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ergotamine-caffeine and dihydroergotamine-caffeine in migraine therapy].
    DALSGAARD-NIELSEN T
    Ugeskr Laeger; 1952 Aug; 114(34):1138-42. PubMed ID: 13015718
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of dihydroergotamine, ergotamine and other agents in the treatment of migraine.
    DANNENBERG T
    Perm Found Med Bull; 1946 Jul; 4():96-103. PubMed ID: 20987521
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacological basis of the treatment of orthostatic disorders with ergot alkaloids.
    Stürmer E
    Cardiology; 1976; 61 suppl 1():290-301. PubMed ID: 975143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation and antagonism of serotonin effects on intracranial and extracranial vessels. Possible implications in migraine.
    Hardebo JE; Edvinsson L; Owman C; Svendgaard NA
    Neurology; 1978 Jan; 28(1):64-70. PubMed ID: 563539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular effects of ergot alkaloids: a study on human basilar arteries.
    Müller-Schweinitzer E
    Gen Pharmacol; 1983; 14(1):95-102. PubMed ID: 6826043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.